Asset
Brinretigene Vesgedparvovec
Editas Medicine Inc. Common Stock
Revenue
No revenue reported in loaded filings.
Clinical trials (1)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT03872479 | phase1_2 | unknown | 2019-09-26 | 2025-05-23 | Editas Medicine, Inc. | Single Ascending Dose Study in Participants With LCA10 |
FDA applications (0)
This company has no applications containing this asset.